Bayer Aktienges ADR (BAYRY)

$10.54 +0.17 (1.63%)
Market Cap 40.75B
Revenue (ttm) 50.43B
Net Income (ttm) -2.76B
EPS (ttm) N/A
PE Ratio 7.21
Forward PE 7.41
Profit Margin -5.48%
Debt to Equity Ratio 1.26
Volume 291,500
Avg Vol 480,248
Day's Range N/A - N/A
Shares Out 3.93B
Stochastic %K 68%
Beta 0.69
Analysts Sell
Price Target $11.05

Company Profile

Bayer Aktiengesellschaft operates as a life science company worldwide. The company operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment provides prescription products primarily for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and contrast agents, as well as cell and gene therapy. The Consumer Health segment markets nonprescription over-the-c...

Industry: Drug Manufacturers - General
Sector: Healthcare
Phone: 49 214 30 1
Address:
Kaiser-Wilhelm-Allee 1, Leverkusen, Germany
BarkingPuppy
BarkingPuppy Dec. 24 at 12:14 AM
$TLRY $JNJ $JAZZ $PFE $BAYRY WE COULD WORK WITH SEVERAL BIG PHARMA COMPANIES. NO OTHER MARIJUANA COMPANY CAN SAY THAT. Big Pharma's involvement is more focused on synthetic cannabinoids or specific cannabis-derived medicines, with GW Pharmaceuticals (now part of Jazz Pharma) leading in approved cannabinoid drugs (Epidiolex), plus companies like Pfizer, Bayer, and Johnson & Johnson exploring cannabinoids for pain/neurology, signaling a shift from recreational growers to pharmaceutical research into cannabis-based treatments. Current Standing in 2025Global Revenue Leader: Following its 2021 merger with Aphria Inc., Tilray established itself as one of the largest cannabis companies globally by revenue and geographic reach. Canadian Market Leader: It remains the #1 cannabis company in Canada by revenue, holding a leading position in the world’s largest federally legal market. European medical cannabis, with significant operations in Portugal and Germany to supply international markets.
0 · Reply
briefingcom
briefingcom Dec. 22 at 1:55 PM
$BAYRY: Bayer AG: Finerenone approved in Japan for treatment of patients with chronic heart failure https://www.briefing.com/in-depth-analysis/content/article?ArticleId=IN20251222062847BAYRY&utm_campaign=inplay&utm_medium=social&utm_source=st&utm_content=view_page
0 · Reply
11thestate
11thestate Dec. 15 at 3:09 PM
Imagine buying $BAYRY at its peak, only to watch it crash like this — and then finding out there’s a way to get some money back. To all $BAYRY investors out there, we’ve got some important news for you: https://11th.com/cases/bayer-investor-settlement
0 · Reply
HereForFunsies
HereForFunsies Dec. 9 at 10:01 PM
$BAYRY those buys were definitely lowered 2 months later, but never stopped! Over 100% rise in the past year. What a trip it has been.
2 · Reply
jagadakku
jagadakku Dec. 9 at 3:05 PM
$BAYRY above 10 we go but we need to get back to the 30s to 40s so it's going to be a ride
0 · Reply
kgnfdeagle
kgnfdeagle Dec. 9 at 12:40 AM
$BAYRY Long and strong from $8.60.
1 · Reply
HereForFunsies
HereForFunsies Dec. 8 at 7:28 PM
$BAYRY ah, here it is. Very nice. https://www.tipranks.com/news/the-fly/bayer-upgraded-to-overweight-from-neutral-at-jpmorgan-thefly?utm_source=robinhood.com&utm_medium=referral
1 · Reply
NEWBIGTECH
NEWBIGTECH Dec. 8 at 3:08 PM
$SLS holding for the buyout offer from $MRK OR $BAYRY BOTH INVOLVED or watching
0 · Reply
HereForFunsies
HereForFunsies Dec. 8 at 2:36 PM
$BAYRY more news or just another wave of buying?
2 · Reply
Turkeymilitary
Turkeymilitary Dec. 5 at 7:42 AM
$ASBP $BAYRY $PFE $LLY
1 · Reply
Latest News on BAYRY
No data available.
BarkingPuppy
BarkingPuppy Dec. 24 at 12:14 AM
$TLRY $JNJ $JAZZ $PFE $BAYRY WE COULD WORK WITH SEVERAL BIG PHARMA COMPANIES. NO OTHER MARIJUANA COMPANY CAN SAY THAT. Big Pharma's involvement is more focused on synthetic cannabinoids or specific cannabis-derived medicines, with GW Pharmaceuticals (now part of Jazz Pharma) leading in approved cannabinoid drugs (Epidiolex), plus companies like Pfizer, Bayer, and Johnson & Johnson exploring cannabinoids for pain/neurology, signaling a shift from recreational growers to pharmaceutical research into cannabis-based treatments. Current Standing in 2025Global Revenue Leader: Following its 2021 merger with Aphria Inc., Tilray established itself as one of the largest cannabis companies globally by revenue and geographic reach. Canadian Market Leader: It remains the #1 cannabis company in Canada by revenue, holding a leading position in the world’s largest federally legal market. European medical cannabis, with significant operations in Portugal and Germany to supply international markets.
0 · Reply
briefingcom
briefingcom Dec. 22 at 1:55 PM
$BAYRY: Bayer AG: Finerenone approved in Japan for treatment of patients with chronic heart failure https://www.briefing.com/in-depth-analysis/content/article?ArticleId=IN20251222062847BAYRY&utm_campaign=inplay&utm_medium=social&utm_source=st&utm_content=view_page
0 · Reply
11thestate
11thestate Dec. 15 at 3:09 PM
Imagine buying $BAYRY at its peak, only to watch it crash like this — and then finding out there’s a way to get some money back. To all $BAYRY investors out there, we’ve got some important news for you: https://11th.com/cases/bayer-investor-settlement
0 · Reply
HereForFunsies
HereForFunsies Dec. 9 at 10:01 PM
$BAYRY those buys were definitely lowered 2 months later, but never stopped! Over 100% rise in the past year. What a trip it has been.
2 · Reply
jagadakku
jagadakku Dec. 9 at 3:05 PM
$BAYRY above 10 we go but we need to get back to the 30s to 40s so it's going to be a ride
0 · Reply
kgnfdeagle
kgnfdeagle Dec. 9 at 12:40 AM
$BAYRY Long and strong from $8.60.
1 · Reply
HereForFunsies
HereForFunsies Dec. 8 at 7:28 PM
$BAYRY ah, here it is. Very nice. https://www.tipranks.com/news/the-fly/bayer-upgraded-to-overweight-from-neutral-at-jpmorgan-thefly?utm_source=robinhood.com&utm_medium=referral
1 · Reply
NEWBIGTECH
NEWBIGTECH Dec. 8 at 3:08 PM
$SLS holding for the buyout offer from $MRK OR $BAYRY BOTH INVOLVED or watching
0 · Reply
HereForFunsies
HereForFunsies Dec. 8 at 2:36 PM
$BAYRY more news or just another wave of buying?
2 · Reply
Turkeymilitary
Turkeymilitary Dec. 5 at 7:42 AM
$ASBP $BAYRY $PFE $LLY
1 · Reply
AanoldMcFace
AanoldMcFace Dec. 4 at 2:06 PM
$BAYRY gonna sell off the whole pump then?
2 · Reply
ZacksResearch
ZacksResearch Dec. 3 at 5:13 PM
$BAYRY jumps 12.1% after Solicitor General's backing for a Supreme Court review of Roundup case 🚀 This legal development has lifted shares, while Bayer's strong YTD performance, up 101.3%, is driven by new drug approvals and pipeline progress, outpacing the industry's 16.1% growth. Discover the full story here 👉 https://www.zacks.com/stock/news/2799148/bayer-stock-up-as-government-backs-supreme-court-review-in-roundup-case?cid=sm-stocktwits-2-2799148-body-23330&ADID=SYND_STOCKTWITS_TWEET_2_2799148_BODY_23330
0 · Reply
ALucci
ALucci Dec. 3 at 5:01 PM
$BAYRY So Quiet in here ...
1 · Reply
HiYoInThere
HiYoInThere Dec. 2 at 4:43 PM
$BAYRY Up 43% on moderate position averaged into many times over the past 3.5 years. Looking for $12 zone to sell first/highest basis tranche then keep holding all the rest longterm.
0 · Reply
OldHam
OldHam Dec. 2 at 3:21 PM
$BAYRY so whats timeline for supreme court to review the case and make a verdict?
1 · Reply
11thestate
11thestate Dec. 2 at 3:10 PM
$BAYRY has agreed to settle with investors over claims that it misled them about its due-diligence process in acquiring Monsanto and the legal risks tied to Roundup litigation. Who’s eligible? Anyone who purchased $BAYRY securities between May 23, 2016 and July 6, 2020. Do I need to sell my shares to qualify? No — you are eligible whether you sold your shares or still hold them. How much is the payout? The payout per share is $0.23 — but if only ~25% of eligible investors file, the effective payout could increase to $0.92. Can I still file? Yes — late claims are currently being accepted, subject to approval. When do payouts happen? Typically within 8–12 months after court approval of the settlement. To file your claim: https://11th.com/cases/bayer-investor-settlement
0 · Reply
jaydilks
jaydilks Dec. 2 at 12:04 PM
$DNA $BAYRY Bayer AG bought Monsanto in 2018 for $63 Billion and became inundated with Roundup lawsuits. Now it looks like Bayer might get some legal relief or at least the potential of it. In October 2022, Ginkgo bought Bayer’s R&D facility including IP for Microbial Strains. This was a big win for Ginkgo but the value of it has been decimated but not gone. It’s still there. With Accounting changes allowing full expensing of R&D, Ginkgo Bioworks is in a very good position to sell R&D services or be acquired by anyone for R&D. I have a funny feeling Bayer will be an active player either by partner or acquirer if they have cash available by not paying lawsuits. Nothing imminent but just a thought.
1 · Reply
HereForFunsies
HereForFunsies Dec. 2 at 10:32 AM
$BAYRY Give us it!! 🎉🍾🥳
0 · Reply
scottptts
scottptts Dec. 2 at 2:23 AM
$BAYRY https://stocks.apple.com/AcihxPuhBTgmwt-OzTCKgxA
1 · Reply
profitraider
profitraider Nov. 24 at 7:18 PM
$BAYRY Gimme Fiddy ✌️
0 · Reply
Smartinvestor79
Smartinvestor79 Nov. 24 at 3:48 PM
$BAYRY won't sell a single share below 20.
1 · Reply
EarlyBirdEmail
EarlyBirdEmail Nov. 24 at 11:45 AM
$ADA.X $BAYRY The recent performance of bonds and how investors should work with bonds right now are two topics discussed in a new episode of the Early Bird podcast. https://www.earlybird.email/p/why-bonds-are-suddenly-booming
0 · Reply